Navin Rajput Mahadevan, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Unfolded Protein Response | 7 | 2017 | 239 | 1.600 |
Why?
|
Small Cell Lung Carcinoma | 6 | 2024 | 451 | 1.570 |
Why?
|
Endoplasmic Reticulum | 4 | 2015 | 1132 | 0.810 |
Why?
|
Immunologic Surveillance | 2 | 2013 | 92 | 0.790 |
Why?
|
Lung Neoplasms | 13 | 2024 | 13451 | 0.690 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2016 | 53 | 0.520 |
Why?
|
Cardiac Tamponade | 1 | 2016 | 176 | 0.470 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3596 | 0.470 |
Why?
|
Lipocalins | 3 | 2012 | 162 | 0.460 |
Why?
|
Primary Myelofibrosis | 1 | 2016 | 210 | 0.450 |
Why?
|
Exodeoxyribonucleases | 2 | 2024 | 191 | 0.410 |
Why?
|
Tumor Microenvironment | 3 | 2015 | 3946 | 0.390 |
Why?
|
Ploidies | 1 | 2012 | 287 | 0.390 |
Why?
|
Neoplasms, Experimental | 2 | 2021 | 1229 | 0.390 |
Why?
|
Acute-Phase Proteins | 3 | 2012 | 252 | 0.380 |
Why?
|
Pericardium | 1 | 2016 | 679 | 0.380 |
Why?
|
Eukaryotic Cells | 1 | 2011 | 192 | 0.350 |
Why?
|
Chordata, Nonvertebrate | 2 | 2008 | 14 | 0.320 |
Why?
|
Phosphoproteins | 3 | 2024 | 2446 | 0.300 |
Why?
|
Oncogene Proteins | 2 | 2011 | 710 | 0.290 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2024 | 5389 | 0.280 |
Why?
|
Neoplasms | 7 | 2024 | 22340 | 0.260 |
Why?
|
T-Box Domain Proteins | 2 | 2008 | 469 | 0.250 |
Why?
|
Cell Line, Tumor | 13 | 2024 | 17075 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8611 | 0.240 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2024 | 2844 | 0.240 |
Why?
|
Branchial Region | 1 | 2004 | 36 | 0.230 |
Why?
|
Proto-Oncogene Proteins | 4 | 2012 | 4520 | 0.220 |
Why?
|
Butyrate Response Factor 1 | 1 | 2022 | 10 | 0.210 |
Why?
|
NF-kappa B | 1 | 2011 | 2485 | 0.200 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2023 | 116 | 0.200 |
Why?
|
Adrenergic Agents | 1 | 2022 | 71 | 0.200 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2013 | 2942 | 0.200 |
Why?
|
Fibroma | 1 | 2023 | 197 | 0.190 |
Why?
|
Dendritic Cells | 1 | 2012 | 2747 | 0.190 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2531 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4642 | 0.180 |
Why?
|
Oxidative Stress | 1 | 2011 | 3141 | 0.170 |
Why?
|
Adaptive Immunity | 2 | 2015 | 734 | 0.170 |
Why?
|
Nucleotides, Cyclic | 1 | 2020 | 83 | 0.170 |
Why?
|
Animals | 23 | 2024 | 168764 | 0.160 |
Why?
|
Membrane Proteins | 4 | 2024 | 7851 | 0.160 |
Why?
|
Spheroids, Cellular | 1 | 2021 | 328 | 0.160 |
Why?
|
Biological Evolution | 1 | 2004 | 1072 | 0.150 |
Why?
|
Epigenomics | 1 | 2024 | 959 | 0.150 |
Why?
|
Prostatic Neoplasms | 3 | 2024 | 11083 | 0.150 |
Why?
|
I-kappa B Kinase | 1 | 2019 | 248 | 0.150 |
Why?
|
Genes, Tumor Suppressor | 1 | 2022 | 1061 | 0.150 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1761 | 0.150 |
Why?
|
Immunity, Innate | 3 | 2024 | 3081 | 0.150 |
Why?
|
Mice | 14 | 2024 | 81819 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 245 | 0.150 |
Why?
|
Mutation | 9 | 2024 | 30198 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2024 | 5337 | 0.140 |
Why?
|
Killer Cells, Natural | 2 | 2024 | 2210 | 0.130 |
Why?
|
Liver | 2 | 2012 | 7562 | 0.130 |
Why?
|
Macrophages | 1 | 2011 | 5772 | 0.130 |
Why?
|
Adenocarcinoma | 2 | 2024 | 6364 | 0.130 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1044 | 0.120 |
Why?
|
Genomics | 4 | 2024 | 5929 | 0.120 |
Why?
|
Thapsigargin | 2 | 2012 | 102 | 0.120 |
Why?
|
GTPase-Activating Proteins | 1 | 2017 | 465 | 0.120 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5849 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1263 | 0.110 |
Why?
|
Pericardial Effusion | 1 | 2016 | 246 | 0.110 |
Why?
|
Myeloid Cells | 2 | 2015 | 839 | 0.110 |
Why?
|
Astrocytoma | 1 | 2017 | 772 | 0.100 |
Why?
|
Cross-Priming | 1 | 2012 | 75 | 0.100 |
Why?
|
Signal Transduction | 5 | 2024 | 23601 | 0.100 |
Why?
|
Humans | 34 | 2024 | 765968 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1510 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2016 | 1831 | 0.090 |
Why?
|
Tunicamycin | 1 | 2011 | 107 | 0.090 |
Why?
|
Hepatocyte Growth Factor | 1 | 2012 | 268 | 0.090 |
Why?
|
Drug Resistance | 1 | 2017 | 1591 | 0.090 |
Why?
|
Phenylbutyrates | 1 | 2011 | 72 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2631 | 0.090 |
Why?
|
Interferons | 2 | 2024 | 714 | 0.080 |
Why?
|
Paclitaxel | 1 | 2017 | 1728 | 0.080 |
Why?
|
Culture Media, Conditioned | 1 | 2011 | 522 | 0.080 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 558 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 3 | 2023 | 1119 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2535 | 0.080 |
Why?
|
Sulfones | 1 | 2011 | 447 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2054 | 0.070 |
Why?
|
Evolution, Molecular | 2 | 2008 | 1889 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2024 | 4274 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2020 | 3584 | 0.070 |
Why?
|
Cell Survival | 1 | 2017 | 5747 | 0.070 |
Why?
|
Tumor Burden | 1 | 2012 | 1885 | 0.070 |
Why?
|
Vertebrates | 2 | 2008 | 227 | 0.070 |
Why?
|
Nitriles | 1 | 2011 | 982 | 0.060 |
Why?
|
Melanoma | 1 | 2024 | 5719 | 0.060 |
Why?
|
Caenorhabditis elegans | 1 | 2015 | 1477 | 0.060 |
Why?
|
Transcription Factor CHOP | 2 | 2017 | 69 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4752 | 0.060 |
Why?
|
Cell Lineage | 2 | 2024 | 2573 | 0.060 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2086 | 0.060 |
Why?
|
Genes, Duplicate | 1 | 2003 | 31 | 0.050 |
Why?
|
GATA3 Transcription Factor | 1 | 2024 | 163 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2021 | 4873 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 2878 | 0.050 |
Why?
|
Extremities | 1 | 2008 | 869 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 158 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2023 | 182 | 0.050 |
Why?
|
Male | 12 | 2024 | 363698 | 0.050 |
Why?
|
Glioma | 1 | 2017 | 3493 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5696 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2900 | 0.050 |
Why?
|
Up-Regulation | 1 | 2011 | 4137 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5501 | 0.050 |
Why?
|
Cohort Studies | 2 | 2022 | 41649 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18293 | 0.050 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 160 | 0.050 |
Why?
|
Heat-Shock Proteins | 2 | 2017 | 791 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 523 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2024 | 385 | 0.040 |
Why?
|
Sequence Alignment | 1 | 2004 | 2171 | 0.040 |
Why?
|
Genes, ras | 1 | 2022 | 658 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 328 | 0.040 |
Why?
|
Nephrectomy | 1 | 2024 | 927 | 0.040 |
Why?
|
Glucose | 1 | 2011 | 4335 | 0.040 |
Why?
|
Biopsy, Fine-Needle | 1 | 2024 | 1133 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2024 | 788 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2012 | 14448 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2024 | 1866 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2022 | 561 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1173 | 0.040 |
Why?
|
Gene Amplification | 1 | 2022 | 1091 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7599 | 0.030 |
Why?
|
Activating Transcription Factor 4 | 1 | 2017 | 86 | 0.030 |
Why?
|
Tubulin Modulators | 1 | 2017 | 107 | 0.030 |
Why?
|
MicroRNAs | 1 | 2012 | 3785 | 0.030 |
Why?
|
eIF-2 Kinase | 1 | 2017 | 145 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2020 | 1336 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2023 | 9550 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2019 | 1679 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9071 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3608 | 0.030 |
Why?
|
Phylogeny | 1 | 2003 | 2832 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1624 | 0.030 |
Why?
|
Serine | 1 | 2019 | 824 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10850 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2045 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3273 | 0.030 |
Why?
|
Genome | 1 | 2003 | 1753 | 0.030 |
Why?
|
Aged | 4 | 2024 | 171117 | 0.030 |
Why?
|
Cytokines | 2 | 2022 | 7421 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2423 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13648 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1874 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2017 | 722 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13400 | 0.030 |
Why?
|
Chromones | 1 | 2012 | 148 | 0.030 |
Why?
|
Tumor Escape | 1 | 2015 | 371 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17594 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2968 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3819 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3426 | 0.020 |
Why?
|
Breast | 1 | 2019 | 1946 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4260 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4424 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2015 | 1250 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2012 | 857 | 0.020 |
Why?
|
Astrocytes | 1 | 2017 | 1345 | 0.020 |
Why?
|
Morpholines | 1 | 2012 | 577 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6113 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2017 | 1608 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2024 | 3181 | 0.020 |
Why?
|
Female | 6 | 2024 | 396112 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8278 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59489 | 0.020 |
Why?
|
Quinolines | 1 | 2012 | 769 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1884 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11641 | 0.020 |
Why?
|
Imidazoles | 1 | 2012 | 1162 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21056 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 223009 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16721 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2453 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12131 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5881 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3715 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2593 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2012 | 3430 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2012 | 3655 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7584 | 0.010 |
Why?
|
Adult | 2 | 2024 | 223044 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15543 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22332 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3607 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 59889 | 0.010 |
Why?
|
Child | 1 | 2017 | 80564 | 0.010 |
Why?
|